India’s generic drugs safe as Trump targets branded pharma imports: Experts
New Delhi: US President Donald Trump’s recent decision to impose a 100 percent import tariff on branded and patented pharmaceutical products starting October 1, 2025, is unlikely to have any immediate impact on Indian pharmaceutical exports, according to key industry players. The move, announced by Trump via his social media platform Truth Social, targets drugmakers not […]